SUBSCRIBE
SUBSCRIBE
News   Drug Development

France’s Ipsen Buys Biotech Firm Sterix

October 19, 2005 | 
1 min read
Private French drugmaker Ipsen said on Thursday it had acquired a small British biotechnology firm prior to a possible initial public offering, in the latest sign of a pick-up in activity in the European sector.
Clinical research Phase 1 IPO Mergers & acquisitions
MORE ON THIS TOPIC
Halftone hand holding pen or stylus and writing on torn paper piece art collage banner template with copy space for text. Cut out shapes, hand gesture. Grunge modern retro vector illustration
Bladder cancer
Merck, Pfizer’s Drug Combo ‘Rewrites the Standard of Care’ in Bladder Cancer
March 2, 2026
 · 
2 min read
 · 
Tristan Manalac
IPO Initial Public Offering finance business concept. 3D render vector illustration of Trading on IPO Initial Public Offering, Business Startup and Stock Market Concept. Public offering share launch
IPO tracker
Generate Clocks Largest IPO Since 2024 With $400M Raise
February 27, 2026
 · 
5 min read
 · 
Tristan Manalac
Insights
ALS Advances Unite Patients and Pharma on Novel Targets, Biomarker Breakthroughs
February 26, 2026
 · 
1 min read
 · 
Jennifer Smith-Parker
Close up shot of the dart arrow hit on bulleyes of dartboard to represent that the business reached the target with dark tone picture style. Target and goal as concept.
Diabetes
Lilly Tops Novo in Weight Loss Again, This Time on the Oral Front
February 26, 2026
 · 
2 min read
 · 
Annalee Armstrong